Seth Loring Harrison's Net Worth
$25.1 Million
Who is Seth Loring Harrison?
Seth Loring Harrison has an estimated net worth of $25.1 Million. This is based on reported shares across multiple companies, which include HeartWare LTD, Stoke Therapeutics, Inc., Akero Therapeutics, Inc., TITAN PHARMACEUTICALS INC, Tokai Pharmaceuticals Inc, and Cerecor Inc..
SEC CIK
Seth Loring Harrison's CIK is 0001404955
Past Insider Trading and Trends
2013 was Seth Loring Harrison's most active year for acquiring shares with 7 total transactions. Seth Loring Harrison's most active month to acquire stocks was the month of April. 2012 was Seth Loring Harrison's most active year for disposing of shares, totalling 13 transactions. Seth Loring Harrison's most active month to dispose stocks was the month of April. 2012 saw Seth Loring Harrison paying a total of $0.00 for 128,979 shares, this is the most they've acquired in one year. In 2016 Seth Loring Harrison cashed out on 143,143 shares for a total of $7,736,794.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
HeartWare LTD No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -151.83K |
$58.00 | -$8,806,082.00 |
0
|
Aug 23
| |||
Form 4
| +0.76% | 1K |
—
|
—
| 133.39K |
Jun 1
| |||
Form 4
| +0.38% | 500 |
—
|
—
| 132.39K |
May 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 3
| |||
Form 4
| +0.19% | 250 |
—
|
—
| 134.89K |
May 12
| |||
Form 4
| +1.13% | 1.5K |
—
|
—
| 134.64K |
May 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 4
| |||
Form 4
| +0.19% | 250 |
—
|
—
| 133.14K |
May 12
| |||
Form 4
| +0.38% | 500 |
—
|
—
| 132.89K |
May 1
| |||
Form 4
| -48.15% | -3.25K |
—
|
—
| 3.5K |
Jan 28
| |||
Form 4
| -5.64% | -7.91K |
$99.29 | -$785,284.61 | 132.39K |
Scheduled
|
Jan 6
| ||
Form 4
| -8.55% | -13.12K |
$95.57 | -$1,253,734.22 | 140.3K |
Jul 1
| |||
Form 4
| -55.60% | -212.43K |
—
|
—
| 169.61K |
May 20 - May 21
| |||
Form 4
| +0.52% | 250 |
—
|
—
| 48.28K |
May 12
| |||
Form 4
| +0.70% | 333 |
—
|
—
| 48.03K |
May 4
| |||
Form 4
| +0.53% | 250 |
—
|
—
| 47.7K |
May 1
| |||
Form 4
| -38.99% | -210.38K |
—
|
—
| 329.25K |
Mar 18
| |||
Form 4
| -15.63% | -1.25K |
—
|
—
| 6.75K |
Mar 11
| |||
Form 4
|
—
|
0
|
—
|
—
| 51.95K |
Jan 16
| |||
Form 4
| -28.05% | -210.38K |
—
|
—
| 539.63K |
Jan 15
| |||
Form 4
| -8.63% | -75.92K |
$81.06 | -$6,150,531.22 | 803.95K |
Dec 14
| |||
Form 4
| -17.54% | -175.41K |
$81.60 | -$14,313,674.92 | 824.92K |
Dec 11 - Dec 13
| |||
Form 4
| -6.86% | -73.63K |
$81.22 | -$5,980,151.00 | 1M |
Dec 7 - Dec 10
| |||
Form 4
| -32.08% | -28.79K |
$90.14 | -$2,595,534.21 | 60.95K |
Scheduled
|
Jul 12 - Jul 16
| ||
Form 4
| -1.35% | -1.23K |
$90.00 | -$110,250.00 | 89.75K |
Scheduled
|
Jul 2 - Jul 3
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 31
| |||
Form 4
| +0.31% | 250 |
—
|
—
| 81.97K |
May 12
| |||
Form 4
| +0.41% | 333 |
—
|
—
| 81.72K |
May 4
| |||
Form 4
| -24.93% | -30.02K |
$77.27 | -$2,319,437.61 | 90.39K |
Scheduled
|
Apr 26
| ||
Form 4
| -28.66% | -479.93K |
—
|
—
| 1.19M |
Mar 1 - Mar 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 12
| |||
Form 4
|
∞
| 334 |
—
|
—
| 334 |
May 4
| |||
Form 4
| -37.40% | -1.00M |
$77.86 | -$77,855,000.00 | 1.67M |
Dec 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 4
| |||
Form 4/A
| +0.05% | 50K |
$0.48 | $24,183.80 | 93.59M |
Sep 10 - Sep 11
| |||
Form 4
| +0.03% | 50K |
$0.49 | $24,183.80 | 187.12M |
Sep 10 - Sep 11
| |||
Form 4
| +0.02% | 20K |
$0.49 | $9,800.00 | 93.53M |
Sep 2
| |||
Form 4
| +0.01% | 5K |
$0.48 | $2,400.00 | 93.54M |
Sep 3
| |||
Form 4
| +0.03% | 25K |
$0.50 | $12,500.00 | 93.51M |
Sep 1
| |||
Form 4
| +0.73% | 680.2K |
$0.51 | $346,900.98 | 93.49M |
Aug 26
| |||
Form 4
| +0.04% | 33.65K |
$0.53 | $17,833.97 | 92.81M |
Aug 22
| |||
Form 4
| +0.20% | 184.45K |
$0.52 | $95,915.56 | 92.77M |
Aug 21
| |||
Form 4/A
| +0.18% | 164.5K |
$0.52 | $85,540.00 | 92.49M |
Aug 15
| |||
Form 4
| +0.11% | 101.7K |
$0.51 | $51,867.00 | 92.59M |
Aug 20
| |||
Form 4
| +0.18% | 164.5K |
$0.52 | $85,540.00 | 92.49M |
Aug 13
| |||
Form 4
| +0.80% | 735.5K |
$0.52 | $382,460.00 | 92.32M |
Aug 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Stoke Therapeutics, Inc. (STOK) Snapshot price: $14.7
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
| +2.23% | 375K |
$39.00 | $14,625,000.00 | 17.16M |
Nov 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 10
| |||
Form 4
|
∞
| 16.79M |
$18.00 | $25,000,002.00 | 16.79M |
Jun 21
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Akero Therapeutics, Inc. (AKRO) Snapshot price: $26.41
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 23
| |||
Form 4
| -7.52% | -23.13K |
$46.94 | -$1,085,739.46 | 284.36K |
Nov 30
| |||
Form 4
| -12.54% | -44.10K |
$40.31 | -$1,777,829.03 | 307.5K |
Oct 28
| |||
Form 4
| -44.81% | -285.49K |
$42.71 | -$12,193,196.37 | 351.6K |
Oct 25 - Oct 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4
| +7.66% | 415K |
$36.00 | $14,940,000.00 | 5.83M |
Jul 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 8
| |||
Form 4
|
∞
| 5.42M |
$16.00 |
—
| 5.42M |
Jun 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
TITAN PHARMACEUTICALS INC (TTNP) Snapshot price: $5.8297
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Tokai Pharmaceuticals Inc (ELDN) Snapshot price: $2.664
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 4
| +87,911,888.89% | 7.91M |
$15.00 |
—
| 7.91M |
Sep 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||